Episode

Metastatic Triple-Negative Breast Cancer — Patterns of Care

Podcast
Breast Cancer Update
Published
Aug 28, 2026
Duration seconds
3743
Processing state
not_requested
Canonical source
https://breast-oncology.captivate.fm/episode/6120-mtnbc26-2
Audio
https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/6722f40f-3115-477f-b9c9-498fb555e15e.mp3
JSON
/v1/public/podcasts/breast-cancer-update-757579/episodes/metastatic-triple-negative-breast-cancer-patterns-of-care
Markdown
/podcast/breast-cancer-update-757579/metastatic-triple-negative-breast-cancer-patterns-of-care.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/breast-cancer-update-757579/episodes/metastatic-triple-negative-breast-cancer-patterns-of-care/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/breast-cancer-update-757579/metastatic-triple-negative-breast-cancer-patterns-of-care.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Featuring perspectives from Prof Peter Schmid and Dr Melinda Telli, including the following topics: Introduction: TROP2-Targeting Antibody-Drug Conjugates (ADCs) for Metastatic Triple-Negative Breast Cancer (0:00) First-Line Therapy (PD-L1 Negative) (6:53) First-Line Therapy (PD-L1 Positive) (23:40) Second-Line Therapy (Sequencing) (34:08) Adverse Events with TROP2-Targeting ADCs (43:43) CME information and select publications